Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a ...

In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold rating on InflaRx (IFRX – Research Report). The company’s shares ...

LifeSci Capital analyst Charles Zhu initiated coverage with a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of ...

Investment analysts at Lifesci Capital boosted their Q1 2025 earnings per share estimates for shares of Corbus ...

Fintel reports that on March 12, 2025, LifeSci Capital initiated coverage of Monte Rosa Therapeutics (NasdaqGS:GLUE) with a ...

Fintel reports that on March 11, 2025, LifeSci Capital initiated coverage of Immunome (NasdaqCM:IMNM) with a Outperform recommendation. Analyst Price Forecast Suggests 250.92% Upside As of March 4 ...

Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Oil & Gas, Technology and Basic Materials ...

In addition to LifeSci Capital, Zymeworks also received a Buy from J.P. Morgan’s Brian Cheng in a report issued on March 6. However, on March 7, H.C. Wainwright reiterated a Hold rating on ...

In Tulsi, a village in central India, social media has sparked an economic and social revolution. It's a microcosm of YouTube's effect on the world. As villagers head into the fields of Tulsi, a ...

On March 16, Barcelona will host its bigger marathon yet, with a record of 27,000 runners racing through the most emblematic spots. The 46th edition of the Zurich Marató Barcelona 2025 has sold ...

Fintel reports that on March 11, 2025, LifeSci Capital initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a Outperform recommendation. As of March 4, 2025, the average one-year price ...